| Ethan Basch, MD |
Prostate, patient-reported outcomes, drug regulatory policy, comparative effectiveness |
| Lisa Carey, MD |
Breast Cancer; clinical/translational research in breast cancer including evaluation of novel drug combinations and clinical implications of molecular sub-typing |
| Cheryl Carlson, MD, PhD |
GI cancers |
| Marjory Charlot, MD, MPH |
Thoracic |
| Frances Collichio, MD |
Melanoma, Breast Cancer, Neuro-oncology and related Phase I/II studies; Associate Fellowship Director and Director for Fellowship Education |
| E. Claire Dees, MD |
Breast cancer and Phase I/development therapeutics |
| Matthew Foster, MD |
Hematologic Malignancies |
| Juneko Grilley-Olson, MD |
Head and neck cancer, lung cancer, sarcomas, developmental therapeutics, Phase I trials |
| Katarzyna Jamieson, MD |
Leukemia, Lymphoma and Myeloma Program, Bone marrow transplantation |
| Trevor Jolly, MBBS |
Geriatric Oncology, Geriatric Assessment of Older Cancer Patients |
| William Kim, MD |
GU cancer and basic investigations in hypoxia-inducible factor (HIF) in tumorigenesis |
| Carrie Lee, MD, MPH |
Melanoma, lung cancer, and Phase I clinical trials (novel anti-cancer agents). |
| Autumn McRee, MD |
GI cancer |
| Matthew Milowsky, MD |
GU malignancies |
| Shannon Morris, MD, PhD |
|
| Stergios Moschos, MD |
Melanoma |
| Hyman Muss, MD |
Breast cancer, geriatric oncology |
| Shetal Patel, MD, PhD |
Thoracic; head and neck |
| Emily Ray, MD, MPH |
Breast cancer |
| Katherine Reeder-Hayes, MD, MBA |
Breast cancer, health services research |
| Hanna Sanoff, MD, MPH |
GI, high risk populations, treatment-related toxicity |
| Jonathan Serody, MD |
Bone Marrow Transplant; dendritic cell vaccine in breast cancer, animal models of graft vs host disease and chemokine activation and regulation |
| Sid Sheth, MD |
Head and neck; thoracic |
| Hendrik van Deventer, MD |
Hematologic malignancies and laboratory investigations in the role of chemokines in the development of tumor metastases |
| Jared Weiss, MD |
Head and neck, thoracic malignancies |
| Young Whang, MD, PhD |
GU malignancies; laboratory-based studies examining aberrant signal transduction pathways and loss of tumor suppressor genes such as PTEN in carcinogenesis |
| William Wood, MD |
Hematologic malignancies, stem cell transplantation, health services |